Outcomes of Carotid Body Tumor Management with Active Surveillance.
Ann Otol Rhinol Laryngol
; 132(5): 551-557, 2023 May.
Article
em En
| MEDLINE
| ID: mdl-35723203
OBJECTIVES: To assess outcomes of carotid body tumors (CBTs) managed with active surveillance. METHODS: Retrospective chart review of CBTs managed with active surveillance from 2001 to 2019. RESULTS: A total of 115 cases were identified during chart review. Sixty-five of these patients were managed with active surveillance, and 11 patients had bilateral tumors for a total of 76 tumors. Follow-up records with symptomatic outcomes were available for 51 patients, and 47 tumors had follow-up imaging. Thirty-one (66%) actively surveilled CBTs remained stable or decreased in size while 16 (34%) increased in size. Patients undergoing active surveillance developed symptoms in 12 cases, 6 of these patients underwent surgical intervention. Nine CBTs managed with active surveillance (18%) were ultimately resected. The majority of patients who did not undergo surgical intervention never developed symptoms (36/42, 86%). CONCLUSIONS: Active surveillance may be a reasonable approach for a subset of CBTs.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Tipos_de_cancer
/
Outros_tipos
Base de dados:
MEDLINE
Assunto principal:
Tumor do Corpo Carotídeo
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
En
Revista:
Ann Otol Rhinol Laryngol
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos